Ngā hua rapu - Rajwanshi, Richa

Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B C... mā Samineni, Divya, Huang, Weize, Gibiansky, Leonid, Ding, Hao, Zhang, Rong, Li, Chunze, Sinha, Arijit, Rajwanshi, Richa, Humphrey, Kathryn, Bazeos, Alexandra, Salem, Ahmed Hamed, Miles, Dale

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial mā Samineni, Divya, Gibiansky, Leonid, Wang, Bei, Vadhavkar, Shweta, Rajwanshi, Richa, Tandon, Maneesh, Sinha, Arijit, Al-Sawaf, Othman, Fischer, Kirsten, Hallek, Michael, Salem, Ahmed Hamed, Li, Chunze, Miles, Dale

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant mā Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Vincenti, Flavio, Woodle, E. Steve, Desai, Niraj, Reed, Elaine F., Tremblay, Simon, Zachary, Andrea A., Vo, Ashley A., Formica, Richard, Schindler, Thomas, Tran, Ha, Looney, Caroline, Jamois, Candice, Green, Cherie, Morimoto, Alyssa, Rajwanshi, Richa, Schroeder, Aaron, Cascino, Matthew D., Brunetta, Paul, Borie, Dominic

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa